Categories AlphaGraphs, Earnings, Health Care

NVAX Earnings: Key highlights from Novavax Q1 2020 results

Coalition for Epidemic Preparedness Innovations (CEPI) increases investment up to $388 million for NVX‑CoV2373 vaccine development & manufacturing

Novavax, Inc. (NASDAQ: NVAX) today announced its first quarter financial results for the period ended March 31, 2020.

NVAX reported net loss of $25.9 million, or $0.58 per share, compared to a net loss of $43.2 million, or $2.11 per share in the first quarter of 2019.

Revenues declined 15% to $3.4 million.

We shared successful pivotal Phase 3 results for NanoFlu that demonstrated both efficacy and safety in a pivotal trial, a significant milestone towards bringing this innovative product to an influenza market in need of new options. We also reacted quickly to the coronavirus pandemic by developing and quickly advancing NVX‑CoV2373, our COVID‑19 vaccine candidate, which shows strong potential to have a positive impact on this global health crisis. Looking ahead, with a strengthened balance sheet and CEPI’s substantial funding, we will focus on scaling up manufacturing and delivering clinical data for NVX‑CoV2373, while simultaneously completing the necessary actions needed to prepare our BLA filing for NanoFlu.

Stanley C. Erck, President and CEO
Novavax Reports First Quarter 2020 Financial Results

Most Popular

Infographic: How Lennar (LEN) performed in Q4 2025

Lennar Corporation (NYSE: LEN) reported total revenues of $9.4 billion for the fourth quarter of 2025, compared to $9.9 billion reported in the same period a year ago. Net earnings

Paychex expected to report higher revenue and earnings for Q2 FY26

Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the

Signet Jewelers (SIG): A look at the progress made on Grow Brand Love

Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top